Core Insights - Milestone Scientific Inc. has launched the commercial rollout of its CompuFlo® Epidural System at Advanced Spine and Pain Management, following a successful pilot program that validated its clinical benefits [1][4] - The CompuFlo® Epidural System utilizes patented Dynamic Pressure Sensing Technology® to provide real-time feedback for accurate needle placement, significantly enhancing patient safety and procedural efficiency [3][5] - The adoption of the CompuFlo® Epidural System is increasing, particularly after the recent Medicare price assignment, indicating its clinical and economic advantages [2][4] Company Overview - Milestone Scientific Inc. is a technology-focused medical research and development company that specializes in innovative injection technologies for medical and dental applications [5] - The company's computer-controlled systems aim to make injections more precise and efficient while improving patient comfort and safety [5] Industry Context - Advanced Spine and Pain Management operates within the SurgiCore network, which consists of 12 centers in the New York/New Jersey metropolitan area, presenting opportunities for further expansion [2] - The integration of the CompuFlo® Epidural System into clinical workflows is expected to enhance care delivery in pain management clinics across the nation [4]

ROSELAND, N.J., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that its CEO Arjan Haverhals and Chairman Neal Goldman will be presenting at The Benchmark Company’s 13th Annual Discovery One-on-One Investor Conference to be held Wednesday, December 11th, 2024 at the New York Athletic Club in New York City. The conference offers emerging growth and dynamic publ ...

Reports 57% increase in international dental sales for the third quarter of 2024 Advances commercial rollout of CompuFlo® Epidural System across additional pain management clinics following Medicare price assignment in multiple U.S. states ROSELAND, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today reported financial results for the third quarter ended September 30, ...

Core Viewpoint - Milestone Scientific Inc. announces the retirement of CEO Arjan Haverhals effective December 31, 2024, while he will continue to serve as a director and consultant to support the leadership transition [1][2]. Leadership Transition - Neal Goldman, Chairman of the Board, will assume the role of Interim CEO following Haverhals' departure, with the Board actively seeking a permanent CEO to lead the company’s growth and commercialization efforts for the CompuFlo® Epidural System [3][4]. CEO Contributions - Haverhals has had a distinguished career of over 30 years in the medical device and pharmaceutical industries, contributing significantly to the financial and operational stability of Milestone Scientific [2][5]. - Under his leadership, the company achieved a granted Medicare Part B Physician payment rate for the CompuFlo® Epidural System, which is a significant milestone for its commercialization [5]. Company Overview - Milestone Scientific Inc. focuses on developing innovative injection technologies aimed at enhancing patient comfort and safety through its proprietary DPS Dynamic Pressure Sensing Technology® [6].

ROSELAND, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, November 15th, 2024, to discuss the company’s financial results for the third quarter ended September 30, 2024, as well as the company’s corporate progress and other developments. The conference call will be available via telep ...

ROSELAND, N.J., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that iHeal Pain Center has adopted the CompuFlo® Epidural System following successful epidural steroid injection (ESI) procedures by Dr. Desai, DO. Dr. Desai has performed six cervical and two lumbar ESI procedures using the CompuFlo® Epidural System, leading to its integration within the clinic. ...

Secured Medicare price assignment for the CompuFlo® Epidural System in multiple U.S. states Gross margin for the second quarter of 2024 increased to 76.1% from 65.0% for the same period last year driven by an increase in U.S. e-commerce sales ROSELAND, N.J., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provides a business update and reported financial results for the ...

ROSELAND, N.J., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments, that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Thursday, August 15th, 2024, to discuss the company's financial results for the second quarter ended June 30, 2024, as well as the company's corporate progress and other developments. The conference call will be available via telephone ...

Core Insights - Milestone Scientific Inc. has announced a strategic partnership with Axial Biologics to distribute its CompuFlo® Epidural System in New Jersey, Texas, and Florida [1][2] - The partnership follows the granting of a Medicare Part B Physician payment rate for the CompuFlo® Epidural System, which is expected to enhance access and adoption within the pain management community, particularly for Medicare patients [2][3] - The CompuFlo® Epidural System is designed to provide precise identification of the epidural space, reducing complications associated with traditional methods, and the recent Medicare Price Assignment is anticipated to facilitate broader adoption across the U.S. [3] Company Overview - Milestone Scientific Inc. focuses on developing innovative injection technologies and instruments for medical and dental applications, utilizing its proprietary DPS Dynamic Pressure Sensing Technology® [5] - Axial Biologics specializes in research and development of regenerative medicine solutions, aiming to enhance patient healing and quality of life [4]

ROSELAND, N.J., July 30, 2024 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE:MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced receipt of multiple Notices of Allowance (NOA) for essential patent applications in both the U.S. and Europe. One NOA was granted by the U.S. Patent and Trademark Office and one NOA was granted by the European Patent Office for a new patent titled "Device and Method for Needle/Catheter Location Uti ...